Stay updated on Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial

Sign up to get notified when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A new site revision entry v3.6.6 was added to the change log, and the prior revision v3.6.5 was removed. This indicates a maintenance/patch update to the site, not a change to the study content or functionality.
    Difference
    0.0%
    Check dated 2026-08-30T06:49:21.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor update to the page's versioning information.
    Difference
    0.0%
    Check dated 2026-08-08T23:14:34.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a newer version of the page content. This reflects an update to the page text or layout.
    Difference
    0.0%
    Check dated 2026-07-25T14:07:09.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    A newer revision identifier appears on the page, indicating a backend or template update; the study content and user-facing information remain unchanged.
    Difference
    0.0%
    Check dated 2026-07-04T04:54:01.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page revision label has been updated from v3.6.0 to v3.6.2, indicating a newer version of the ClinicalTrials.gov study page.
    Difference
    0.0%
    Check dated 2026-06-27T02:55:15.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    The study page now indicates recruitment is closed and results have been posted. New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the 28-day treatment cycle duration is stated.
    Difference
    6%
    Check dated 2026-06-12T16:53:09.000Z thumbnail image

Stay in the know with updates to Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.